All ProductsDisplaying Products Alphabetically by Name (L)
Cat. No. | Product Name / Activity |
---|---|
3066 | L 006235 |
Potent cathepsin K inhibitor | |
5085 | L 012 sodium salt |
Chemiluminescent ROS and RNS indicator | |
4013 | L 760735 |
High affinity NK1 antagonist | |
6251 | L Moses dihydrochloride |
High affinity and selective PCAF bromodomain inhibitor | |
1382 | L-152,804 |
Potent, selective non-peptide NPY Y5 receptor antagonist | |
2514 | L-161,982 |
Selective EP4 receptor antagonist | |
2311 | L-168,049 |
Potent, orally active human glucagon receptor antagonist | |
2767 | L-365,260 |
Selective CCK2 antagonist | |
2641 | L-368,899 hydrochloride |
Potent, non-peptide oxytocin receptor antagonist | |
2410 | L-371,257 |
Potent and selective oxytocin receptor antagonist | |
3086 | L-651,582 |
Non-selective Ca2+ channel blocker | |
1327 | L-655,708 |
Benzodiazepine inverse agonist; selective for α5-containing GABAA receptors | |
2627 | L-685,458 |
Potent and selective γ-secretase inhibitor | |
0742 | L-689,560 |
Highly potent NMDA antagonist | |
0681 | L-690,330 |
Inositol monophosphatase inhibitor | |
0705 | L-701,252 |
NMDA antagonist; acts at glycine site | |
0907 | L-701,324 |
NMDA antagonist; acts at glycine site | |
1145 | L-733,060 hydrochloride |
Potent NK1 antagonist | |
1004 | L-741,742 hydrochloride |
Highly selective D4 antagonist | |
1003 | L-741,626 |
High affinity D2 antagonist | |
1002 | L-745,870 trihydrochloride |
Highly selective D4 antagonist | |
2760 | L-748,337 |
Selective β3 antagonist | |
2197 | L-755,507 |
Very potent and selective β3 partial agonist | |
3342 | L-798,106 |
Potent and highly selective EP3 antagonist | |
1980 | L-817,818 |
Potent and selective sst5 agonist | |
3250 | L-838,417 |
GABAA partial agonist; displays subtype selectivity | |
6954 | L-Buthionine sulfoximine |
Irreversible γ-glutamylcysteine synthetase (γ-GCS) inhibitor; induces ferroptosis | |
3788 | L-DOPA |
Dopamine precursor | |
6146 | LAP |
Photocrosslinker for hydrogels | |
7420 | LC 2 |
Selective KRAS Degrader (PROTAC®) | |
7421 | LC 2 Epimer |
Negative control for LC 2 (Cat. No. 7420) | |
5592 | LCB 03-0110 dihydrochloride |
Potent c-SRC kinase inhibitor; also inhibits DDR2, BTK and Syk | |
7178 | LCL 161, phenol |
Functionalized IAP ligand for PROTACs | |
5631 | LDN 193188 |
Inhibitor of phosphatidylcholine transfer protein (PC-TP) | |
6053 | LDN 193189 dihydrochloride |
Potent and selective ALK2 and ALK3 inhibitor; inhibits BMP4 signaling; promotes neural induction of hPSCs | |
8150 | LDN 193189 in solution New |
Sterile-filtered 10 mM solution of LDN 193189 pre-dissolved in water | |
TB6053-GMP | LDN 193189 |
LDN 193189 synthesized to cGMP guidelines | |
7020 | LDV |
α4β1 (VLA-4) ligand | |
4577 | LDV FITC |
Fluorescent ligand for α4β1 (VLA-4) | |
2021 | LE 135 |
Selective RARβ antagonist | |
1674 | LE 300 |
Potent and selective D1 antagonist | |
5826 | LEI 101 hydrochloride |
Potent and selective CB2 partial agonist; orally biovailable | |
7407 | LEI 401 |
High affinity N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD) inhibitor | |
1300 | LFM-A13 |
Potent, selective BTK inhibitor | |
5920 | LG 100268 |
Potent and selective RXR agonist; also activates RXR/PPARγ heterodimers | |
8095 | LIH 383 New |
Atypical chemokine receptor (ACKR3) agonist | |
4745 | LIMKi 3 |
Potent LIM kinase inhibitor; antitumor | |
6754 | LJI308 |
Potent pan-RSK inhibitor | |
5213 | LL 37 |
Antimicrobial peptide derivative of human cathelicidin | |
7813 | LL-K9-3 |
Selective HyT-based degrader of the CDK9-cyclin T1 complex | |
4607 | LM 22A4 |
Potent TrkB agonist | |
5046 | LM11A 31 dihydrochloride |
Nonpeptide p75NTR ligand; neuroprotective | |
6037 | LM22B 10 |
TrkB and TrkC agonist; brain penetrant | |
6510 | LNT 1 |
Potent flap endonuclease 1 (FEN1) inhibitor; induces DNA damage response | |
6691 | LP 922056 |
Notum inhibitor; activates Wnt signaling | |
5496 | LP 99 |
Selective BRD7 and BRD9 inhibitor | |
3394 | LRGILS-NH2 |
Control peptide for SLIGRL-NH2 (Cat. No. 1468) | |
4273 | LRRK2-IN-1 |
Potent and selective LRRK2 inhibitor | |
5275 | LSN 2463359 |
Potent and selective positive allosteric modulator of mGlu5 receptors | |
7959 | LSN 3318839 New |
Glucagon-like peptide-1 receptor (GLP1-R) positive allosteric modulator | |
3562 | LU AA33810 |
Potent NPY Y5 receptor antagonist | |
4603 | LUF 5834 |
Potent adenosine A2A and A2B receptor partial agonist | |
6322 | LW 6 |
Malate dehydrogenase-2 (MDH2) inhibitor; also inhibits HIF-1α | |
7027 | LY 2033298 |
Selective positive allosteric modulator of M4 receptors; active in vivo; antipsychotic | |
4141 | LY 2087101 |
Allosteric potentiator of α7, α4β2 and α4β4 nAChRs | |
7864 | LY 2109761 |
Selective TGF-β kinase inhibitor | |
6964 | LY 2119620 |
Positive allosteric modulator of M2 and M4 receptors | |
1018 | LY 225910 |
Potent CCK2 antagonist | |
3397 | LY 2365109 hydrochloride |
Potent and selective GlyT1 inhibitor | |
2208 | LY 255283 |
Selective, competitive BLT2 receptor antagonist | |
6454 | LY 2603618 |
Potent and selective Chk1 inhibitor | |
4081 | LY 266097 hydrochloride |
Selective 5-HT2B antagonist | |
3077 | LY 272015 hydrochloride |
High affinity 5-HT2B antagonist; orally active | |
1524 | LY 288513 |
Selective CCK2 antagonist | |
7081 | LY 2886721 Hydrochloride |
Potent and selective β-secretase (BACE) inhibitor | |
1130 | LY 294002 hydrochloride |
Prototypical PI 3-kinase inhibitor; also inhibits other kinases | |
5984 | LY 2955303 |
High affinity and selective RARγ antagonist | |
3078 | LY 310762 hydrochloride |
Selective 5-HT1D antagonist | |
1209 | LY 341495 |
Highly potent and selective group II mGlu antagonist | |
4062 | LY 341495 disodium salt |
Potent and selective group II mGlu antagonist; disodium salt of LY 341495 (Cat. No. 1209) | |
2451 | LY 344864 hydrochloride |
Potent and selective 5-HT1F agonist | |
3246 | LY 354740 |
Potent and highly selective group II mGlu agonist | |
1237 | LY 367385 |
Selective mGlu1a antagonist | |
2453 | LY 379268 |
Highly selective group II mGlu agonist | |
5064 | LY 379268 disodium salt |
Selective group II mGlu agonist; sodium salt of LY 379268 (Cat. No. 2453) | |
5297 | LY 404187 |
Selective positive allosteric modulator of AMPA receptors | |
6559 | LY 450139 |
γ-secretase pseudo-inhibitor | |
2390 | LY 456236 hydrochloride |
Selective mGlu1 antagonist | |
3283 | LY 487379 hydrochloride |
Selective positive allosteric modulator of mGlu2 receptors | |
6617 | LYN 1604 dihydrochloride |
Potent UNC-51-like kinase 1 (ULK1) agonist | |
2267 | Lactacystin |
Cell-permeable, potent and selective proteasome inhibitor | |
6098 | Lalistat 1 |
Potent and selective LAL inhibitor | |
6099 | Lalistat 2 |
Selective LAL inhibitor | |
1611 | Lamotrigine |
Inhibits glutamate release. Anticonvulsant | |
2289 | Lamotrigine isethionate |
Inhibits glutamate release. Water-soluble salt of lamotrigine (Cat. No. 1611) | |
6811 | Lapatinib |
Potent and selective dual ErbB2 (HER-2) and EGFR inhibitor | |
7343 | Laropiprant |
Potent and selective prostaglandin D2 receptor antagonist | |
3973 | Latrunculin A |
Inhibitor of actin assembly and polymerization | |
3974 | Latrunculin B |
Inhibitor of actin polymerization | |
7275 | Laurdan |
Polarity sensitive lipid membrane fluorescent probe. Used for: imaging lipid rafts. Application: fluorescent microscopy | |
2460 | Lazabemide hydrochloride |
Selective MAO-B inhibitor | |
6305 | Lenalidomide |
Cereblon binder; induces ubiquitination and degradation of CK1α by E3 ubiquitin ligase | |
7075 | Lenalidomide 4'-PEG1-amine |
Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
7513 | Lenalidomide 4'-PEG1-azide |
Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
7093 | Lenalidomide 4'-PEG2-amine |
Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
7514 | Lenalidomide 4'-PEG2-azide |
Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
7076 | Lenalidomide 4'-PEG3-amine |
Cereblon ligand with PEG linker and terminal amine for onward chemistry | |
7516 | Lenalidomide 4'-alkylC3-azide |
Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
7517 | Lenalidomide 4'-alkylC5-azide |
Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
7677 | Lenalidomide 5'-amine |
Cereblon ligand with terminal amine for onward chemistry | |
7472 | Lenalidomide 5'-piperazine |
Cereblon ligand with terminal piperazine for onward chemistry | |
7473 | Lenalidomide 5'-piperazine-4-methylpiperidine |
Cereblon ligand with terminal piperidine for onward chemistry | |
3395 | Lestaurtinib |
JAK2, FLT3 and TrkA inhibitor; also inhibits AurA and AurB | |
4382 | Letrozole |
Potent, reversible non-steroidal aromatase inhibitor | |
2307 | Leukotriene B4 |
BLT1/BLT2 receptor agonist and potent chemotactic factor | |
1167 | Leupeptin hemisulfate |
Inhibits trypsin-like/cysteine proteases | |
1378 | Levcromakalim |
Kir6 (KATP) channel opener; active enantiomer of Cromakalim | |
2839 | Levetiracetam |
Binds SV2A; antiepileptic | |
2705 | Liarozole dihydrochloride |
Blocks retinoic acid metabolism | |
3865 | Licarbazepine |
Active metabolite of oxcarbazepine (Cat. No. 3864) | |
3057 | Lidocaine |
Na+ channel blocker | |
6068 | Lin28 1632 |
RNA binding protein Lin28 inhibitor; promotes mESC differentiation; also bromodomain inhibitor | |
3765 | Linezolid |
Antibiotic; inhibits protein synthesis in gram-positive bacteria | |
7743 | Linifanib |
Potent inhibitor of PDGFRβ, KDR, FLT3 and CSF-1R | |
1999 | Linopirdine dihydrochloride |
KV7 (KCNQ) channel blocker | |
7652 | Linsitinib |
Potent and selective dual inhibitor of the IGF-1 receptor and insulin receptor | |
6113 | Liproxstatin-1 hydrochloride |
Potent ferroptosis inhibitor | |
6517 | Liraglutide |
Highly potent, long-acting GLP-1 receptor agonist | |
4052 | Lisuride maleate |
Dopamine agonist; antiparkinson's agent | |
4359 | Lomeguatrib |
MGMT inhibitor | |
7492 | Lomitapide mesylate |
Potent microsomal triglyceride transfer protein (MTP) inhibitor | |
6265 | Lonafarnib |
Potent farnesyltransferase inhibitor | |
1646 | Lonidamine |
Mitochondrial hexokinase inhibitor | |
0840 | Loperamide hydrochloride |
Peripherally acting μ agonist; Ca2+ channel blocker | |
7052 | Lopinavir |
Highly potent and selective HIV-1 protease inhibitor | |
1295 | Loreclezole hydrochloride |
Subtype-selective GABAA modulator | |
3798 | Losartan potassium |
Selective, non-peptide AT1 antagonist | |
1530 | Lovastatin |
Potent HMG-CoA reductase inhibitor | |
3036 | Loxiglumide |
CCK1 antagonist; active in vivo | |
5427 | D-Luciferin sodium salt |
Firefly luciferase substrate; cell permeable. | |
2874 | Luteolin |
Anti-inflammatory, antioxidant and free radical scavenger | |
0877 | Luzindole |
Competitive melatonin MT1/MT2 antagonist |
Tocris Products by Catalog Number
0100020003000400050006000700080009001000110012001300140015001600170018001900200021002200230024002500260027002800290030003100320033003400350036003700380039004000410042004300440045004600470048004900500051005200530054005500560057005800590060006100620063006400650066006700680069007000710072007300740075007600770078007900800081008200830084008500860087008800